Hemab Therapeutics Holdings, Inc. Common Stock (COAG) — Net Asset Quality Index
Hemab Therapeutics Holdings, Inc. Common Stock (COAG) has a Net Asset Quality Index of -90.7% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $194.78 Million minus total liabilities of $371.42 Million yields net assets of $-176.63 Million. A higher index indicates a stronger, lower-leverage balance sheet. For live market cap and overall valuation, see COAG stock market capitalisation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Hemab Therapeutics Holdings, Inc. Common Stock Net Asset Quality Index Over Time (2024–2025)
This chart shows how Hemab Therapeutics Holdings, Inc. Common Stock's Net Asset Quality Index has evolved across 2 annual periods from 2024 to 2025. As of December 2025, the index stands at -90.7%, representing net assets of $-176.63 Million against total assets of $194.78 Million USD. See net assets of Hemab Therapeutics Holdings, Inc. Common for net asset value and shareholders' equity analysis.
Annual Net Asset Quality Index for Hemab Therapeutics Holdings, Inc. Common Stock (2024–2025)
The table below presents the year-by-year Net Asset Quality Index for Hemab Therapeutics Holdings, Inc. Common Stock from 2024 to 2025, covering 2 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Also explore COAG year-over-year net asset growth to track the company's year-over-year net asset growth rate.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -90.7% | $-176.63 Million | $194.78 Million | $371.42 Million | ▲ +29.0 pp |
| 2024 | -119.7% | $-115.27 Million | $96.28 Million | $211.55 Million | — |